An Osaka Metropolitan University study on over 500,000 lung cancer patients found that higher BMI lowered death risk during both immunotherapy and chemotherapy. However, this trend reversed at a BMI of 24. For those under a BMI of 28, immunotherapy had a lower risk than chemotherapy, but for patients with a BMI of 28 or higher, immunotherapy increased risk.
Impact of BMI on cancer treatment survival rates
Obesity and immunotherapy survival
- Advertisement -
Explore more ..
High-fat diets and memory loss- A reversible story
Machine learning identifies early depression signals in facial patterns.
Why alcohol halts liver regeneration, even after quitting
New research links inflammation to faulty RNA processing
Breakthrough stool test could replace invasive colonoscopies
An artificial intelligence-based approach to diagnose colorectal cancer from the gut microbiota.
TRENDING
- Advertisement -